Global Health Updates: Mpox Vaccine Aid, Major Biopharma Deals, and New Medical Innovations

This summary of current health news briefs covers Germany's donation of mpox vaccines to Africa, delays in vaccine deliveries to Congo, major sales and acquisitions in the biopharma industry, and new medical innovations. The global health scenario is evolving rapidly with various countries and companies actively involved in combating health issues.

Germany is set to donate 100,000 mpox vaccine doses from its military stocks to Africa, aiming to curb the outbreak on the continent. The German government will also provide the World Health Organization with flexible financial resources to support affected countries through the GAVI vaccination alliance.

In a development in the Democratic Republic of Congo, authorities no longer expect the arrival of mpox vaccines this week despite the country facing a new variant of the virus. In other biopharma news, Belgium’s UCB has announced the sale of its Chinese neurology and allergy business for $680 million to Singapore-based CBC and Abu Dhabi's Mubadala.

Additionally, McKesson is set to buy a controlling stake in Florida Cancer Specialists' unit for $2.5 billion in cash. Meanwhile, Cigna plans to remove AbbVie's Humira from its preferred drug lists by 2025 in favor of less expensive biosimilars. The Philippines has reported two new cases of the milder mpox clade 2 variant, and Brazil has confirmed a suspected mpox case at Sao Paulo airport.